R&D

R&D

Digitalization and the Future of Formulating in Modern R&D Labs

This webinar will focus on the benefits of implementing a true data infrastructure, and the challenges that organizations will face along this journey.

04.12.21

R&D

Small Innovators & Niche CROs

Smaller CROs have the opportunity to provide a niche approach to its clients, particularly smaller sponsors who have shared synergies.

Neil Goodman, David Bruce and Mohamed El Malt, Europital 04.01.21

Analytical Services | Bioanalytical Services | Laboratory Testing | R&D

Rapid and Data Rich Chromatographic Method Development

An overview of what to consider when developing chromatographic methods.

Daniel Kirschner, Executive Director of Analytical Services, Cambrex - Durham, North Carolina 04.01.21

Laboratory Testing | R&D

How Modern Near-Infrared Came to Be

First region outside the visible to be discovered and last to be utilized.

Gary E. Ritchie, Contributing Writer 04.01.21

Enteris BioPharma: Custom Solutions – From Bench to Market

CDMO operations are housed within a 32,000-square-foot, FDA-inspected and cGMP-compliant facility in northern New Jersey.

Sponsored released by Enteris BioPharma 04.01.21

Breaking News | R&D

JSR Life Sciences Unveils Corporate Venture Fund

Aims to foster investment in new companies and innovative technologies.

Charles Sternberg, Assistant Editor 03.24.21

Innoforce and dMed Enter Development Collaboration

Aims to accelerate the development of innovative therapeutics.

Tim Wright, Editor, Contract Pharma 03.03.21

Breaking News | CRO News | Drug Discovery | Industry News | R&D

Icon to Acquire PRA Health Sciences

Brings together two organizations to create a leading healthcare intelligence and clinical CRO.

Charles Sternberg, Assistant Editor 03.01.21

CatSci Opens New Site in UK

Strengthens analytical capabilities with the opening of a secondary site in Dagenham backed by a $4.2 million investment.

Tim Wright, Editor, Contract Pharma 02.25.21

Almac Group Completes $7M R&D Center

Significant expansion of biocatalysis, flow chemistry, and peptide capacity.

Tim Wright, Editor, Contract Pharma 02.23.21

Breaking News | R&D

Wavelength Pharmaceuticals Acquires Majority Stake in Vanamali Organics

Further strengthens its drug substance manufacturing footprint and global supply chain.

Charles Sternberg, Assistant Editor 02.18.21

Jubilant Biosys, Yale Form Research Alliance

Aims to accelerate small molecule discovery programs leveraging Jubilant's medicinal chemistry, structural biology, in-vitro and in-vivo pharmacology.

02.10.21

cGMP Manufacture | Drug Development | Process Development | R&D

Importance of Green Chemistry in Drug Development And Manufacturing

Learn how one CDMO is at the forefront of green chemistry, applying its principles to reduce the environmental and human impact of pharmaceutical production.

Breaking News | Collaborations & Alliances | Drug Discovery | Industry News | R&D

Almac Sciences Secures Support from Invest NI

Accelerates enzyme discovery program.

Contract Pharma Staff 01.13.21

Breaking News | Collaborations & Alliances | Drug Discovery | Industry News | R&D

Mogrify Enters Research Collaboration with MRC LMB

Research project aims to develop novel protein expression systems via cell reprogramming.

Contract Pharma Staff 01.11.21

Breaking News | cGMP Manufacture | Drug Development | Industry News | R&D

Ascentage Selects PharmaBlock as Preferred Provider

PharmaBlock will support Ascentage in accelerating its drug development pipeline with R&D, manufacturing capacity, and technological solutions.

Contract Pharma Staff 12.11.20

Evotec and Sartorius Partner with Curexsys

Leverage IPSC platform for scalable manufacturing of Curexsys' exosome-based therapeutics.

Contract Pharma Staff 12.09.20

Breaking News | CRO News | Industry News | R&D

LINK Medical Acquires IRW Consulting AB

Strengthens its position in the Nordics while improving its offerings and capabilities.

Contract Pharma Staff 12.09.20

Breaking News | Industry News | R&D

Colorcon Ventures Invests in i20 Therapeutics

Will work together to accelerate i2O’s research and development efforts.

Contract Pharma Staff 12.07.20

R&D

With a specialized focus on semi-solids and liquids, DPT offers pharmaceutical companies the broadest range of capabilities in the industry. From R&D formulation to commercial-scale manufacturing, small batches to large, liquids to emulsions, sterile or non-sterile, we offer clients of all sizes the most effective resources for meeting challenges.

Stacy London, Marketing Manager 11.30.20